Search Results for "R"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for R. Results 371 to 380 of 996 total matches.

Tramadol - A New Oral Analgesic

   
The Medical Letter on Drugs and Therapeutics • Jul 07, 1995  (Issue 952)
have a beneficial effect on pain (R Lee et al, Drugs, 46:313, 1993). The analgesic effect of tramadol is only ...
Tramadol hydrochloride (Ultram - Ortho-McNeil), a centrally-acting analgesic marketed in Germany since 1977, was recently approved by the US Food and Drug Administration for oral treatment of moderate to moderately severe pain. Despite some opioid activity, tramadol has not been scheduled as a controlled substance.
Med Lett Drugs Ther. 1995 Jul 7;37(952):59-60 |  Show IntroductionHide Introduction

Topical Drugs for Aging Skin

   
The Medical Letter on Drugs and Therapeutics • Aug 15, 1997  (Issue 1007)
Thorne in R Marks, ed, Retinoids in Cutaneous Malignancy, Oxford:Blackwell, 1991, page 66). Adverse ...
Topical tretinoin (all-trans-retinoic acid) has been used for years to treat skin damaged by chronic exposure to the sun (Medical Letter, 34:28, 1992). First approved by the FDA only for treatment of acne in concentrations ranging from 0.025% to 0.1% (Retin-A, and others), it has now been approved as an 0.05% formulation in an emollient cream base (Renova) for topical treatment of photodamaged skin. In recent years, alpha-hydroxy acids incorporated in some cosmetics have also been promoted as effective in improving the appearance of aging skin.
Med Lett Drugs Ther. 1997 Aug 15;39(1007):78-9 |  Show IntroductionHide Introduction

Creatine and Androstenedione--Two "Dietary Supplements"

   
The Medical Letter on Drugs and Therapeutics • Nov 06, 1998  (Issue 1039)
(VB Mahesh and RB Greenblatt, Acta Endocrinol, 41:400, 1962). Data from a German patent application (R ...
Creatine, a natural amino acid derivative, and androstenedione, a testosterone precursor, are marketed as 'dietary supplements' in health food stores and are widely believed to enhance athletic performance. Both have been in the news recently because Mark McGwire, the baseball home-run record-setter, reportedly has said he takes both. Neither has been approved for any indication by the US Food and Drug Administration (FDA).
Med Lett Drugs Ther. 1998 Nov 6;40(1039):105-6 |  Show IntroductionHide Introduction

Entacapone for Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Jan 24, 2000  (Issue 1070)
., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Richard ...
Entacapone (Comtan), a catechol-O-methyltransferase (COMT) inhibitor, has been approved by the FDA for adjunctive use with levodopa/carbidopa in patients with Parkinson's disease who have end-of-dose "wearing off"symptoms.
Med Lett Drugs Ther. 2000 Jan 24;42(1070):7-8 |  Show IntroductionHide Introduction

Phytoestrogens

   
The Medical Letter on Drugs and Therapeutics • Feb 21, 2000  (Issue 1072)
. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Richard Kim, M.D., Vanderbilt ...
Phytoestrogens, plant compounds that are converted to estrogens in the gut, are widely promoted as "natural"substitutes for estrogen in hormone replacement therapy.
Med Lett Drugs Ther. 2000 Feb 21;42(1072):17-8 |  Show IntroductionHide Introduction

Exemestane For Advanced Breast Cancer

   
The Medical Letter on Drugs and Therapeutics • Apr 17, 2000  (Issue 1076)
Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D ...
The FDA has approved exemestane, an aromatase inhibitor, for the treatment of postmenopausal women with advanced breast cancer that has progressed during treatment with tamoxifen.
Med Lett Drugs Ther. 2000 Apr 17;42(1076):35-6 |  Show IntroductionHide Introduction

Ciclopirox (Penlac) Nail Lacquer for Onychomycosis

   
The Medical Letter on Drugs and Therapeutics • Jun 12, 2000  (Issue 1080)
of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Richard Kim, M.D ...
Ciclopirox nail lacquer (Penlac - Dermik) has been approved by the FDA for treatment of mild-to-moderate onychomycosis due to Trichophyton rubrum, without involvement of the lunula. The drug has been available for many years as a lotion and cream (Loprox) for treatment of cutaneous fungal infection
Med Lett Drugs Ther. 2000 Jun 12;42(1080):51-2 |  Show IntroductionHide Introduction

Photodynamic Therapy With Verteporfin (Visudyne) For Macular Degeneration

   
The Medical Letter on Drugs and Therapeutics • Sep 04, 2000  (Issue 1086)
., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Mathew ...
Photodynamic therapy with verteporfin (Visudyne--CIVA Vision), an injectable drug, is now being used for treatment of age-related macular degeneration. The drug is a benzoporphyrin derivative that, when activated by light in the presence of oxygen, generates highly reactive radicals that damage neovascular endorthelium and occlude the vessels.
Med Lett Drugs Ther. 2000 Sep 4;42(1086):81-2 |  Show IntroductionHide Introduction

Rivastigmine (Exelon) For Alzheimer's Disease

   
The Medical Letter on Drugs and Therapeutics • Oct 02, 2000  (Issue 1089)
of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Mathew Maurer, M.D ...
Rivastigmine tartrate (Exelon - Novartis), a carbamate-based cholinesterase inhibitor, is now being marketed for treatment of patients with dementia due to Alzheimer's disease.
Med Lett Drugs Ther. 2000 Oct 2;42(1089):93-4 |  Show IntroductionHide Introduction

Automated External Defibrillators

   
The Medical Letter on Drugs and Therapeutics • Dec 11, 2000  (Issue 1094)
of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Mathew Maurer, M.D ...
Recent studies suggest that timely use of automated external defibrillators operated by laypersons with minimal training can save lives. Purchase of these devices for public places or home use requires authorization from a physician.
Med Lett Drugs Ther. 2000 Dec 11;42(1094):116 |  Show IntroductionHide Introduction